Jacobs Levy Equity Management
GLSI icon

Jacobs Levy Equity Management’s Greenwich LifeSciences GLSI Stock Holding History

Jacobs Levy Equity Management’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,809
Closed -$368K – 1061
2021
Q1 		$368K Buy
+10,809
New +$368K ﹤0.01% 906

Other funds holding GLSI

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SW
SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jacobs Levy Equity Management's GLSI Position: Q2 2021 in Review

Jacobs Levy Equity Management sold out of Greenwich LifeSciences (GLSI) in Q2 2021, closing a stake of 10,809 shares — an estimated $368K sold.

Jacobs Levy Equity Management first reported a position in GLSI in Q1 2021 and held it in 1 quarter. The position peaked at $368K in Q1 2021. 30 funds tracked by Wall St. Rank hold GLSI as of Q2 2021.

  • Jacobs Levy Equity Management reported no remaining Greenwich LifeSciences position as of Q2 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 10,809 Greenwich LifeSciences shares in Q2 2021, an estimated $368K.
  • Jacobs Levy Equity Management first reported a position in Greenwich LifeSciences in Q1 2021 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Greenwich LifeSciences position peaked at $368K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.